What is Profound Medical's R&D?

Profound Medical (PROF) reported R&D of $5.26M in Q1 2026.

How has Profound Medical's R&D changed year-over-year?

Profound Medical's R&D increased by 9.4% year-over-year, from $4.81M to $5.26M.

What is the long-term trend for Profound Medical's R&D?

Over 2 years (2023 to 2025), Profound Medical's R&D has grown at a 19.5% compound annual growth rate (CAGR), from $14.42M to $20.6M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Profound Medical PROF R&D

R&D at other companies

Intuitive SurgicalISRG

$361.9M+14.5%

TriSalus Life Sciences, Inc.TLSI

$3.22M+6.5%

BioventusBVS

$2.47M-18.1%

Other financials

Income statement

See full

Revenue$5.3M+104%

Gross profit$3.8M+107%

Operating income-$8.0M+28.2%

Net income-$7.1M+34.2%

EPS (diluted)$0.19-47.2%

Balance sheet

See full

Cash & equivalents$50.3M+8.3%

Total debt$7.5M+52.8%

Total equity$59.4M+17.0%

Total assets$73.5M+20.7%

Cash flow

See full

Operating cash flow-$8.6M-3.6%

CapEx$44.0K—

Free cash flow-$9.6M—

Valuation

See full

Market cap$241.65M+30.7%

Enterprise value$198.81M+28.7%

P/S12.8×-2.8×

Profitability

See full

Gross margin71.1%+3.4pp

Operating margin-202.6%-51.3pp

Net margin-206.8%-39.0pp

FCF margin-238.4%—

Returns & leverage

See full

Return on equity-70.6%+4.8pp

Debt / equity0.1×0.0×

Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Profound Medical's R&D?: Profound Medical (PROF) reported R&D of $5.26M in Q1 2026.
How has Profound Medical's R&D changed year-over-year?: Profound Medical's R&D increased by 9.4% year-over-year, from $4.81M to $5.26M.
What is the long-term trend for Profound Medical's R&D?: Over 2 years (2023 to 2025), Profound Medical's R&D has grown at a 19.5% compound annual growth rate (CAGR), from $14.42M to $20.6M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.